SerenQ MT2 10mg Peptide Pen

Description

SereneQ Melanotan-2

Melanotan-2 is a synthetic cyclic heptapeptide analogue of alpha-melanocyte stimulating hormone (α-MSH). It was developed at the University of Arizona in the 1980s as part of a programme to find a photoprotective compound, and its structure was modified from the natural α-MSH linear peptide to increase potency and resistance to enzymatic degradation. Unlike Melanotan-1 (afamelanotide), which was developed specifically for its selective MC1R activity, Melanotan-2 is non-selective and activates MC1R, MC3R and MC4R — which is what gives it a broader and more complex effect profile.

What the research covers

The melanocortin receptor system sits within the central nervous system and in peripheral tissue. MC1R is expressed in melanocytes and governs pigmentation and UV protection — that is the pathway the University of Arizona programme was targeting. MC3R and MC4R are expressed in the hypothalamus and other CNS areas. MC4R activation is what produces the sexual arousal effects documented in early male subject studies, as well as the appetite suppression observed in some research. MC3R is involved in energy homeostasis. The three pathways operating simultaneously is what makes MT-2 a complex research compound with a wide effect profile at varying doses.

Where the evidence sits

Early human studies established proof-of-concept for pigmentation and sexual arousal in small groups. There are no large-scale controlled trials. MT-2 was not taken forward commercially due to the breadth of its receptor activity — PT-141 (bremelanotide) was derived from MT-2 but cyclised differently to reduce the erection-inducing effect for the female arousal indication. MT-2 does not hold a medicines licence anywhere. Supplied strictly as a laboratory research chemical.

The pen format

This is where SereneQ does things differently. Instead of lyophilised vials that need reconstituting and drawing up separately, the compound arrives pre-loaded in solution in a graduated injection pen with a dial and a dose window.

• 11.55mg MT-2 total in 3ml (116% of 10mg label claim — batch tested)
• 3.85mg/ml · approx 38.5mcg per unit
• Graduated dial with dose window
• 300 units total per pen
• 4 × sealed pen tips, 32G 0.23 × 4mm
• Batch number, expiry and serial printed directly on the pen barrel
• Store refrigerated at 2–8°C. Protect from light.

Handling and storage

• Store refrigerated at 2–8°C. Do not freeze.
• Keep in the outer carton, away from direct light.
• Short periods at room temperature during transit are expected and normal.
• Use a fresh sealed tip for each dispense. Dispose of tips in a sharps container.
• Expiry 12/2027 on sealed, correctly stored stock.
• Keep out of reach of children and animals.

What is in the box

• 1 × SereneQ pre-filled injection pen
• 4 × sealed pen tips, 32G 0.23 × 4mm
• Serialised, QR-coded retail carton

Supplied strictly as a laboratory research chemical. Not licensed as a medicine in the UK or anywhere else. Not for human or veterinary use. The research cited covers animal and in vitro work unless otherwise stated.